ESCRS - Preloaded intraocular lens injection system ;
ESCRS - Preloaded intraocular lens injection system ;

Preloaded intraocular lens injection system

Latest news from the industry in October 2016 EuroTimes

Preloaded intraocular lens injection system
Colin Kerr
Colin Kerr
Published: Friday, September 30, 2016
rayner_2658 Rayner launched the RayOne®, their fully preloaded intraocular lens (IOL) injection system, at the XXXIV Congress of the ESCRS in Copenhagen. Designed from the outset to work together, the RayOne lens and injector makes micro-incision cataract surgery (MICS) quicker and easier with the smallest-tipped preloaded IOL system currently on the market, said CEO Tim Clover. Ease of use and safety were RayOne design priorities, Clover added. Patented “Lock & Roll” technology rolls the lens tightly before pushing it forward in the fully enclosed cartridge, enabling smooth, consistent injection with minimum force and maximum control. The 1.65mm nozzle is parallel-sided for minimal stretch, supporting wound-in lens injection through sub-2.2mm incisions. www.rayner.com FDA APPROVAL The Medical Technology Business Group of Zeiss has announced FDA approval of the VisuMax® small incision lenticule extraction (SMILE) procedure. “I thank the surgeons and clinics who have paved the way for Zeiss to be able to bring this new innovative technology to refractive practices throughout the US,” said James V Mazzo, Global President of Ophthalmic Devices, and President and CEO of the company’s US organisation. www.zeiss.com NEW CEO appointed Avedro, Inc. has announced the appointment of Reza Zadno, medical device entrepreneur, as the company’s CEO. “We are very pleased to have Reza join Avedro’s senior executive team as CEO,” said Gil Kliman, Managing Director at InterWest Partners, and a member of the Avedro Board of Directors. “His entrepreneurial skills and proven leadership will help assure the successful commercialisation of 
our recently FDA-approved crosslinking device and drugs in the US, and speed our clinical development 
of PiXL, a first-in-category, non-surgical procedure for the correction of myopia.” www.avedro.com
Tags: IOLs, SMILE
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;